Jim Simons acquired 66.9k Palvella Therapeutics shares worth $3.62M. That's 0.00% of their equity portfolio (1730th largest holding). The investor owns 20.16% of the outstanding Palvella Therapeutics stock. The first Palvella Therapeutics trade was made in Q4 2024. Since then Jim Simons bought shares one more times and sold shares on one occasions. The stake costed the investor $1.56M, netting the investor a gain of 132% so far.